ArticleClinical pharmacology and therapeutics2026
Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA-Authorised Medicines.
Maja J Jørgensen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.